New Delhi: Aurobindo Pharma Limited announced that its wholly owned subsidiary, Eugia Pharma Specialities Limited, has received final approval from the US Food and Drug Administration (USFDA) for Everolimus Tablets…
FDA Commissioner Marty Makary defended the agency’s recent rejections of rare disease drugs and one of his deputies, Vinay Prasad, in an interview with CNBC.
A new study published in the journal of BMC Surgery showed that shorter operational time, less intraoperative blood loss, a shorter postoperative hospital stays, and a higher textbook outcome (TO)…
The FDA has approved dupilumab (Dupixent) for the treatment of allergic fungal rhinosinusitis (AFRS), marking the first approved therapy for this condition. The approval applies to adults and children aged…
USA: A novel multi-modal artificial intelligence (AI) system integrating two-dimensional (2D) and three-dimensional (3D) mammography significantly improves breast cancer screening efficiency. A prospective multicenter study published in Nature Medicine in…
A new study published in the journal of Chest Pulmonary showed that nephrolithiasis is more common in Black women in the United States who have sarcoidosis. Non-necrotizing granulomas are a…
The findings of a new study suggest a possible association between H. pylori infection and the pathophysiology of vitiligo. Based on this link, H. pylori eradication therapy may serve as…
Sarepta CEO steps down, an experimental cell therapy rejection, and more biotech news
An experimental therapy for a rare blood cancer was rejected by the FDA though internal reviewers had recommended it be cleared
Here are the top health stories for the day:NEET-MDS 2026: Registrations To Open Soon, Exam On May 2The National Board of Examinations in Medical Sciences (NBEMS) will soon begin registration…